This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2016 Dec 1:224:15-17.

doi: 10.1016/j.ijcard.2016.08.316. Epub 2016 Aug 23.

Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy

Deepakraj Gajanana¹, Mahek Shah², Parichart Junpapart², Abel Romero-Corral², Vincent M Figueredo², Behnam Bozorgnia²

Affiliations

Affiliations

¹ Albert Einstein Medical Center, Philadelphia, PA, United States. Electronic address: gajanade@einstein.edu.
² Albert Einstein Medical Center, Philadelphia, PA, United States.

PMID: 27599385
DOI: 10.1016/j.ijcard.2016.08.316

Comparative Study

Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy

Deepakraj Gajanana et al. Int J Cardiol. 2016.

. 2016 Dec 1:224:15-17.

doi: 10.1016/j.ijcard.2016.08.316. Epub 2016 Aug 23.

Authors

Deepakraj Gajanana¹, Mahek Shah², Parichart Junpapart², Abel Romero-Corral², Vincent M Figueredo², Behnam Bozorgnia²

Affiliations

¹ Albert Einstein Medical Center, Philadelphia, PA, United States. Electronic address: gajanade@einstein.edu.
² Albert Einstein Medical Center, Philadelphia, PA, United States.

PMID: 27599385
DOI: 10.1016/j.ijcard.2016.08.316

No abstract available

Keywords: Guideline directed medical therapy; Ischemic cardiomyopathy; Non-ischemic cardiomyopathy; Systolic heart failure.

PubMed Disclaimer

Similar articles

Predictors of mortality in medically treated patients with congestive heart failure of nonrheumatic etiology and reduced systolic function.
Bajraktari G, Emini M, Shabani X, Berisha V, Selmani H, Rexhepaj N, Elezi S, Ndrepepa G. Bajraktari G, et al. Eur J Intern Med. 2009 Jul;20(4):362-5. doi: 10.1016/j.ejim.2008.09.011. Epub 2008 Nov 6. Eur J Intern Med. 2009. PMID: 19524174
No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy.
de Groote P, Lamblin N, Mouquet F, Bauters C. de Groote P, et al. Arch Cardiovasc Dis. 2008 Apr;101(4):242-8. doi: 10.1016/s1875-2136(08)73699-4. Arch Cardiovasc Dis. 2008. PMID: 18654099
Mortality reduction with beta-blockers in ischemic cardiomyopathy patients undergoing coronary artery bypass grafting.
Lin T, Hasaniya NW, Krider S, Razzouk A, Wang N, Chiong JR. Lin T, et al. Congest Heart Fail. 2010 Jul-Aug;16(4):170-4. doi: 10.1111/j.1751-7133.2010.00146.x. Congest Heart Fail. 2010. PMID: 20662870
Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.
Walters AM, Porter GA Jr, Brookes PS. Walters AM, et al. Circ Res. 2012 Oct 12;111(9):1222-36. doi: 10.1161/CIRCRESAHA.112.265660. Circ Res. 2012. PMID: 23065345 Free PMC article. Review.
Pharmacological treatment of chronic systolic heart failure: are we scraping the bottom of the barrel?
Abate E, Sartor R, Ceconi C, Boffa GM. Abate E, et al. J Cardiovasc Med (Hagerstown). 2010 Dec;11(12):893-905. doi: 10.2459/JCM.0b013e328339d884. J Cardiovasc Med (Hagerstown). 2010. PMID: 20414119 Review.

See all similar articles

Cited by

Epidemiology and management of heart failure with reduced ejection fraction in a Tunisian university hospital.
Drissa M, Drissa H, Helali S, Oughlani K, Farah A, Chebbi M. Drissa M, et al. Cardiovasc J Afr. 2023 May-Jun 23;34(2):68-72. doi: 10.5830/CVJA-2018-070. Epub 2023 May 3. Cardiovasc J Afr. 2023. PMID: 37132406 Free PMC article.
Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis.
Rangwala BS, Zuhair V, Mustafa MS, Mussarat A, Khan AW, Danish F, Fatima Zaidi SM, Rehman FU, Shafique MA. Rangwala BS, et al. Future Sci OA. 2024 Dec 31;10(1):2367956. doi: 10.1080/20565623.2024.2367956. Epub 2024 Jul 9. Future Sci OA. 2024. PMID: 38982752 Free PMC article. Review.
Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction- Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries).
Tymińska A, Ozierański K, Balsam P, Maciejewski C, Wancerz A, Brociek E, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Opolski G, Grabowski M, Kapłon-Cieślicka A. Tymińska A, et al. Biology (Basel). 2022 Feb 21;11(2):341. doi: 10.3390/biology11020341. Biology (Basel). 2022. PMID: 35205207 Free PMC article.
A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs.
Lu Y, Wang D, Zhu Y, Du Y, Zhang J, Yang H. Lu Y, et al. Front Pharmacol. 2022 Nov 28;13:1039857. doi: 10.3389/fphar.2022.1039857. eCollection 2022. Front Pharmacol. 2022. PMID: 36518671 Free PMC article.
Prevalence of non-acute ischaemic cardiomyopathy in a Pakistani cohort.
Ghazni MS, Aijaz S, Malik R, Pathan AZ. Ghazni MS, et al. Heart Asia. 2019 Mar 25;11(1):e011043. doi: 10.1136/heartasia-2018-011043. eCollection 2019. Heart Asia. 2019. PMID: 31031826 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information